Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial

Update: 2024-05-16

Description

Co-Editor-in-Chief Jasmohan S. Bajaj, MD, MS, FACG interviews Anand V. Kulkarni, MD, DM about the ARiE Trial, an RCT published in the May 2024 issue. (12:40 )

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

2024-12-1018:15

Risk Factors for Serrated Polyps: Results From a Large, Multicenter Colonoscopy-Based Study

2024-12-0318:20

Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study

2024-11-0411:56

Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus

2024-08-0109:35

Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy

2024-07-3109:41

ACG Clinical Guideline: Focal Liver Lesions

2024-07-1113:27

Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial

2024-05-1612:40

Risk of Esophageal Cancer in Achalasia: A Matched Cohort Study Using the Nationwide Veterans Affairs Achalasia Cohort

2024-04-2916:10

Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis

2024-03-2510:47

ACG Clinical Guideline: Acute Pancreatitis

2024-03-0518:47

ACG Clinical Guideline: Alcohol-Associated Liver Disease

2024-01-0316:32

Post-Endoscopy Care for Patients Presenting with Esophageal Food Bolus Impaction: A Population-Based Multicenter Cohort Study

2023-10-0408:41

AGA-ACG Clinical Guideline: Pharmacological Management of Chronic Idiopathic Constipation

2023-08-3125:41

ACG Clinical Guideline: Acute Liver Failure

2023-07-2718:20

ACG Clinical Guideline: Diagnosis and Management of Celiac Disease

2023-03-0610:46

ACG Clinical Guideline: Diagnosis and Management of Biliary Strictures

2023-03-0215:39

Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline

2023-02-0314:57

ACG Clinical Guideline: Gastrointestinal Subepithelial Lesions

2023-01-1817:49

Gravity and the Gut: A Hypothesis of IrritableBowel Syndrome

2022-12-0220:33

Impact of Obesity on Risk of Hospitalization, Surgery and Serious Infection in Biologic-treated Patients with IBD

2022-11-1109:04

00:00

Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial

Jasmohan S. Bajaj, MD, MS, FACG and Anand V. Kulkarni, MD, DM

#box-pro-ellipsis-173453380768158{-webkit-line-clamp:2;}Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial

Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial

Jasmohan S. Bajaj, MD, MS, FACG and Anand V. Kulkarni, MD, DM

Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial